Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
86DA
Posted in: MTFB.L
Posts: 302
Price: 2.65
No Opinion
There is a link to the conference call on Motifs website. You'll have to register to hear it.
Price: 2.84
Must be spotty.Have you tried anti-biotics.Its Iclaaaaaprrinnnn, Its Iclaaaaaprrinnnn !
Have you done any climbing,I've been up Everest twice.Lovely girl !
Its a rich mans word.Been had over by a Lumsden, its a rich mans world.Not added to my pension pot, its a rich mans world.
Price: 2.80
JimziI cant figure it out either, whats another P3 Trial going to prove?
Price: 8.80
The FDA guidance says 30 days after meeting, i would assume 30 calendar days.I make that the 2nn June.
Price: 7.40
Is it conceivable that the FDA issued a CRL to force MTFB to do Phase IV trials, which they wouldn't have done with a straight approval?
Sorry try this http://www.lse.co.uk/share-regulatory-news.asp?shareprice=MTFB&share=motif_bio
**************************************/rns/announcement/0abf5f4e-e57f-413e-8b6e-da15a4d6999c
Price: 7.50
Have also pledged all there Polarean shares to one of there lender. They have lots of debt and no income, Mr Micawber wouldn't be happy.
Yes AMP said they would sell $750,000 dollars worth, which would have got them down to approx 18m shares.Last Friday they seem to have sold an extra 2m getting them down to 16m.
AMP said in March they would sell down to 18m, the lender to decide when.They have now sold another 2m down to 16m, Lots of debt no income.
Price: 7.75
Antares Pharma Xyosted is quiet a good case study for our situationhttps://www.globenewswire.com/news-release/2018/03/27/1453473/0/en/Antares-Pharma-Provides-XYOSTED-Regulatory-Update.htmlThey got an unexpected CRL, but went on to get approval.
It wont be long now and well know one way or another.
The process is to re-submit the NDA either 2 months or 6 months.After 30 days the FDA would confirm a Complete Response to the earlier deficiencies, then issue a end date for approval.of course we were confident of approval in Feb.
Is this you Scotty https://www.securitieslawyersblog.com/broker-investigation-customer-complaints-scott-palmer/I realise its not your real name.
Won't the Board hold warrants or options to buy shares as part of there remuneration?
Is it the Federal Government Shut Down, December 22, 2018 until January 25, 2019 ?
Price: 7.22
You can download Form 20-F from Motif Bios website.
Price: 7.86
Article from about one year ago about small companies and CRL'shttps://www.evaluate.com/vantage/articles/data-insights/are-small-companies-carrying-complete-response-letter-can
Login failed